The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Eli Lilly and Company .

Filed returns
7
match these filters
Matching filed returns per period 0 0 1 1 2 Jan–Apr 2020: 1 filed returns Sep–Dec 2020: 1 filed returns May–Aug 2024: 2 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns May–Aug 2026: 1 filed returns 2020 2025
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Eli Lilly and Company Economic Development and Industry EU and Irish life sciences policy development and competitiveness (Public policy or programme) 9 On lobbying.ie
May–Aug 2025 Eli Lilly and Company Trade Discuss the risks of potential tariffs on the complex global supply chains for innovative medicines (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2025 Eli Lilly and Company EU Affairs Advocate for improved EU Environment to support investment in medicines innovation and manufacturing (Public policy or programme) 3 On lobbying.ie
May–Aug 2024 Eli Lilly and Company Economic Development and Industry Project Progress and Economic Impact of Lilly Limerick. (Public policy or programme) 3 On lobbying.ie
May–Aug 2024 Eli Lilly and Company Economic Development and Industry Project Progress and Economic Impact of Lilly Limerick. (Public policy or programme) 11 On lobbying.ie
Sep–Dec 2020 Eli Lilly and Company Health Update on clinical research and product development carried out by Eli Lilly and Company with respect to treatments for Covid-19 (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2020 Eli Lilly and Company Economic Development and Industry Definition of "Essential Work" under the Covid-19 Regulations and Restrictions. (Public policy or programme) 4 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Economic Development and Industry 4 57.1%
EU Affairs 1 14.3%
Health 1 14.3%
Trade 1 14.3%